Amedisys (AMED) Tops Q1 EPS by 21c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance
April 30, 2019 4:34 PM EDTBATON ROUGE, La., April 30, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2019.
Three Month Periods Ended March 31, 2019 and 2018
Net service revenue increased $68.0Â million to $467.3Â million compared to $399.3Â million in 2018.Net income attributable to Amedisys, Inc. of $31.3Â million compared to $27.2Â million in 2018.Net income attributable to Amedisys, Inc. per diluted share of $0.95 per diluted share compared to $0.79 in 2018.Adjusted Quarterly Results*
Adjusted EBITDA of $54.9Â million compared to $41.7Â million in 2018.Adjusted net service revenue of $467.8Â million compared to $399.3Â million in... More